← Leaderboards
Jeffrey I Zink
University Of California Los Angeles
$4,550,823
Attributed
$10,398,077
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $987.9K · FY2010–24$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,398,077 · 5
By mechanism
R01$6,491,536 · 3
U01$2,377,645 · 1
U19$1,528,896 · 1
Top collaborators
- Andre Elias Nel18 shared
- James Fraser Stoddart8 shared
- Fuyuhiko Tamanoi8 shared
- Timothy R Donahue5 shared
- Huan Meng5 shared
- Otger Campas4 shared
- Ellen May Sletten4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Andre Elias Nel$21,296,649
- Jing Wen$2,923,926
- Fuyuhiko Tamanoi$5,574,151
- James Fraser Stoddart$522,761
- Masakazu Kamata$5,573,549
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleResponseSilicon DioxideDesignNanoTumorPharmaceutical PreparationsUptakeCellsSiteTargeted DeliveryChemotherapeutic AgentEnvironmentSurfacePreventEncapsulatedMalignant NeoplasmsStimulusBaseCancer CellDrug Delivery SystemsNovel StrategiesSolidChemotherapy-Oncologic Procedure
Grant awards (27)
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy$479,283
R01 · FY2024 · CA
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy$512,817
R01 · FY2023 · CA
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy$529,313
R01 · FY2022 · CA
Robust microdroplet-based mechanical probes for wide-ranging mechanobiology applications$434,815
R01 · FY2022 · GM
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy$553,064
R01 · FY2021 · CA
Robust microdroplet-based mechanical probes for wide-ranging mechanobiology applications$434,815
R01 · FY2021 · GM
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy$553,064
R01 · FY2020 · CA
Robust microdroplet-based mechanical probes for wide-ranging mechanobiology applications$434,815
R01 · FY2020 · GM
Robust microdroplet-based mechanical probes for wide-ranging mechanobiology applications$468,508
R01 · FY2019 · GM
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$433,388
U01 · FY2019 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$459,169
U01 · FY2018 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$476,683
U01 · FY2017 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$495,258
U01 · FY2016 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$513,147
U01 · FY2015 · CA
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$380,516
R01 · FY2014 · CA
Scientific Core: Acquisition, Synthesis, and Characterization of Nanomaterials$323,242
U19 · FY2014 · ES · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$22,823
R01 · FY2014 · CA
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$369,346
R01 · FY2013 · CA
Scientific Core: Acquisition, Synthesis, and Characterization of Nanomaterials$367,670
U19 · FY2013 · ES · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$64,637
R01 · FY2013 · CA
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$393,575
R01 · FY2012 · CA
Scientific Core: Acquisition, Synthesis, and Characterization of Nanomaterials$295,037
U19 · FY2012 · ES · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$45,234
R01 · FY2012 · CA
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$394,252
R01 · FY2011 · CA
Scientific Core: Acquisition, Synthesis, and Characterization of Nanomaterials$245,481
U19 · FY2011 · ES · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$420,659
R01 · FY2010 · CA
Scientific Core: Acquisition, Synthesis, and Characterization of Nanomaterials$297,466
U19 · FY2010 · ES · contact PI